Advisory Services Network’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-50
Closed -$325 3785
2023
Q4
$325 Buy
+50
New +$322 ﹤0.01% 3678
2023
Q2
Sell
-14,912
Closed -$280K 3783
2023
Q1
$280K Sell
14,912
-7,375
-33% -$121K 0.01% 1166
2022
Q4
$307K Sell
22,287
-1,250
-5% -$19.1K 0.01% 1071
2022
Q3
$450K Sell
23,537
-7,000
-23% -$128K 0.02% 854
2022
Q2
$466K Hold
30,537
0.02% 861
2022
Q1
$622K Buy
+30,537
New +$622K 0.02% 818
2021
Q3
Sell
-5,033
Closed -$129K 3330
2021
Q2
$129K Buy
+5,033
New +$108K ﹤0.01% 1480
2021
Q1
Sell
-5,114
Closed -$59K 3033
2020
Q4
$59K Hold
5,114
﹤0.01% 1581
2020
Q3
$39K Buy
+5,114
New +$38.7K ﹤0.01% 1721
2020
Q2
Sell
-7,830
Closed -$40K 2830
2020
Q1
$40K Buy
+7,830
New +$47.4K ﹤0.01% 1501

Other funds holding CDMO

Advisory Services Network's CDMO Position: Q1 2024 in Review

Advisory Services Network sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2024, closing a stake of 50 shares — an estimated $325 sold.

Advisory Services Network first reported a position in CDMO in Q1 2020 and held it in 10 quarters. The position peaked at $622K in Q1 2022. 166 funds tracked by Wall St. Rank hold CDMO as of Q1 2024.

  • Advisory Services Network reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Advisory Services Network sold 50 Avid Bioservices, Inc. Common Stock shares in Q1 2024, an estimated $325.
  • Advisory Services Network first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2020 and held it in 10 quarters.
  • Advisory Services Network's Avid Bioservices, Inc. Common Stock position peaked at $622K in Q1 2022.
  • 166 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2024.

Based on Advisory Services Network's 13F filing for Q1 2024, filed 6 May 2024.